These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 16608091)

  • 21. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.
    Malhotra-Kumar S; Van Heirstraeten L; Lammens C; Chapelle S; Goossens H
    J Antimicrob Chemother; 2009 May; 63(5):886-94. PubMed ID: 19279051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid detection of gyrA and parC mutations in fluoroquinolone-resistant Neisseria gonorrhoeae by denaturing high-performance liquid chromatography.
    Shigemura K; Shirakawa T; Okada H; Tanaka K; Udaka T; Kamidono S; Arakawa S; Gotoh A
    J Microbiol Methods; 2004 Dec; 59(3):415-21. PubMed ID: 15488283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction of the fitness burden of quinolone resistance in Pseudomonas aeruginosa.
    Kugelberg E; Löfmark S; Wretlind B; Andersson DI
    J Antimicrob Chemother; 2005 Jan; 55(1):22-30. PubMed ID: 15574475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial susceptibility and molecular determinants of quinolone resistance in Neisseria gonorrhoeae isolates from Shanghai.
    Yang Y; Liao M; Gu WM; Bell K; Wu L; Eng NF; Zhang CG; Chen Y; Jolly AM; Dillon JA
    J Antimicrob Chemother; 2006 Oct; 58(4):868-72. PubMed ID: 16880174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of the mechanisms of fluoroquinolone resistance in urinary tract pathogens.
    Chenia HY; Pillay B; Pillay D
    J Antimicrob Chemother; 2006 Dec; 58(6):1274-8. PubMed ID: 17040923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patterns of quinolone susceptibility in Campylobacter jejuni associated with different gyrA mutations.
    McIver C; Hogan T; White P; Tapsall J
    Pathology; 2004 Apr; 36(2):166-9. PubMed ID: 15203753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brevundimonas diminuta infections and its resistance to fluoroquinolones.
    Han XY; Andrade RA
    J Antimicrob Chemother; 2005 Jun; 55(6):853-9. PubMed ID: 15883180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of the CmeABC efflux pump in the emergence of fluoroquinolone-resistant Campylobacter under selection pressure.
    Yan M; Sahin O; Lin J; Zhang Q
    J Antimicrob Chemother; 2006 Dec; 58(6):1154-9. PubMed ID: 17023497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiological characteristics and molecular basis of fluoroquinolone-resistant Neisseria gonorrhoeae strains isolated in Korea and nearby countries.
    Yong D; Kim TS; Choi JR; Yum JH; Lee K; Chong Y; Oh HB; Shultz T; Tapsall JW
    J Antimicrob Chemother; 2004 Aug; 54(2):451-5. PubMed ID: 15231766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Type II topoisomerase mutations in clinical isolates of Enterobacter cloacae and other enterobacterial species harbouring the qnrA gene.
    Lascols C; Robert J; Cattoir V; Bébéar C; Cavallo JD; Podglajen I; Ploy MC; Bonnet R; Soussy CJ; Cambau E
    Int J Antimicrob Agents; 2007 Apr; 29(4):402-9. PubMed ID: 17254753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of topoisomerase mutations in fluoroquinolone-resistant and -susceptible Campylobacter jejuni strains isolated in Senegal.
    Kinana AD; Cardinale E; Bahsoun I; Tall F; Sire JM; Garin B; Boye CS; Dromigny JA; Perrier-Gros-Claude JD
    Int J Antimicrob Agents; 2007 Apr; 29(4):397-401. PubMed ID: 17224260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of gyrA and parC mutations in enterococci from environmental samples with reduced susceptibility to ciprofloxacin.
    Petersen A; Jensen LB
    FEMS Microbiol Lett; 2004 Feb; 231(1):73-6. PubMed ID: 14769469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Accumulation and efflux of quinolones by clinical isolates of Stenotrophomonas maltophilia].
    Sánchez P; Alonso A; Campanario E; Alós I; Martíinez JL
    Rev Esp Quimioter; 2000 Jun; 13(2):176-81. PubMed ID: 10918091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of efflux pumps and topoisomerase mutations in fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli.
    Ge B; McDermott PF; White DG; Meng J
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3347-54. PubMed ID: 16048946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A nucleotide mutation associated with fluoroquinolone resistance observed in gyrA of in vitro obtained Rhodococcus equi mutants.
    Niwa H; Hobo S; Anzai T
    Vet Microbiol; 2006 Jun; 115(1-3):264-8. PubMed ID: 16563665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complete nucleotide sequence of the gyrA gene of Helicobacter pullorum and identification of a point mutation leading to ciprofloxacin resistance in poultry isolates.
    Pasquali F; Rossi M; Manfreda G; Zanoni R
    Int J Antimicrob Agents; 2007 Sep; 30(3):222-8. PubMed ID: 17644320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial resistance of Neisseria gonorrhoeae in Japan, 1993-2002: continuous increasing of ciprofloxacin-resistant isolates.
    Tanaka M; Nakayama H; Notomi T; Irie S; Tsunoda Y; Okadome A; Saika T; Kobayashi I
    Int J Antimicrob Agents; 2004 Sep; 24 Suppl 1():S15-22. PubMed ID: 15364300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India.
    Gaind R; Paglietti B; Murgia M; Dawar R; Uzzau S; Cappuccinelli P; Deb M; Aggarwal P; Rubino S
    J Antimicrob Chemother; 2006 Dec; 58(6):1139-44. PubMed ID: 17071955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro-selected resistance to fluoroquinolones in two Brucella strains associated with mutational changes in gyrA.
    Turkmani A; Psaroulaki A; Christidou A; Chochlakis D; Tabaa D; Tselentis Y
    Int J Antimicrob Agents; 2008 Sep; 32(3):227-32. PubMed ID: 18583100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular characterization of enrofloxacin resistant Actinobacillus pleuropneumoniae isolates.
    Wang YC; Chan JP; Yeh KS; Chang CC; Hsuan SL; Hsieh YM; Chang YC; Lai TC; Lin WH; Chen TH
    Vet Microbiol; 2010 May; 142(3-4):309-12. PubMed ID: 19913366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.